vs

Side-by-side financial comparison of Red Cat Holdings, Inc. (RCAT) and Semler Scientific, Inc. (SMLR). Click either name above to swap in a different company.

Red Cat Holdings, Inc. is the larger business by last-quarter revenue ($9.6M vs $7.5M, roughly 1.3× Semler Scientific, Inc.). Semler Scientific, Inc. runs the higher net margin — 225.6% vs -166.0%, a 391.7% gap on every dollar of revenue. On growth, Red Cat Holdings, Inc. posted the faster year-over-year revenue change (988.2% vs -44.6%).

Mega Cat Studios is an American video game development and publishing company located in Pittsburgh, Pennsylvania. It was founded in 2015 by James Deighan, Nick Mann, and Zack Manko.

Semler Scientific, Inc. develops, manufactures and distributes non-invasive medical diagnostic devices for chronic disease screening. Its flagship QuantaFlo system delivers fast, accurate peripheral arterial disease testing, serving hospitals, clinics, primary care practices and other healthcare providers primarily in the United States.

RCAT vs SMLR — Head-to-Head

Bigger by revenue
RCAT
RCAT
1.3× larger
RCAT
$9.6M
$7.5M
SMLR
Growing faster (revenue YoY)
RCAT
RCAT
+1032.8% gap
RCAT
988.2%
-44.6%
SMLR
Higher net margin
SMLR
SMLR
391.7% more per $
SMLR
225.6%
-166.0%
RCAT

Income Statement — Q3 FY2025 vs Q3 FY2025

Metric
RCAT
RCAT
SMLR
SMLR
Revenue
$9.6M
$7.5M
Net Profit
$-16.0M
$16.9M
Gross Margin
6.6%
91.5%
Operating Margin
-181.7%
-72.0%
Net Margin
-166.0%
225.6%
Revenue YoY
988.2%
-44.6%
Net Profit YoY
-29.0%
201.3%
EPS (diluted)
$-0.16
$1.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RCAT
RCAT
SMLR
SMLR
Q3 25
$9.6M
$7.5M
Q2 25
$8.2M
Q1 25
$1.6M
$8.8M
Q4 24
$0
$12.4M
Q3 24
$13.5M
Q2 24
$14.5M
Q1 24
$5.8M
$15.9M
Q4 23
$15.1M
Net Profit
RCAT
RCAT
SMLR
SMLR
Q3 25
$-16.0M
$16.9M
Q2 25
$66.9M
Q1 25
$-23.1M
$-64.7M
Q4 24
$-13.3M
$29.2M
Q3 24
$5.6M
Q2 24
$11.0K
Q1 24
$-5.5M
$6.1M
Q4 23
$4.2M
Gross Margin
RCAT
RCAT
SMLR
SMLR
Q3 25
6.6%
91.5%
Q2 25
91.0%
Q1 25
-52.2%
89.4%
Q4 24
91.1%
Q3 24
91.4%
Q2 24
91.3%
Q1 24
18.8%
92.2%
Q4 23
77.5%
Operating Margin
RCAT
RCAT
SMLR
SMLR
Q3 25
-181.7%
-72.0%
Q2 25
-25.0%
Q1 25
-765.7%
-352.0%
Q4 24
28.5%
Q3 24
37.5%
Q2 24
37.0%
Q1 24
-76.0%
43.9%
Q4 23
16.7%
Net Margin
RCAT
RCAT
SMLR
SMLR
Q3 25
-166.0%
225.6%
Q2 25
814.6%
Q1 25
-1418.9%
-732.3%
Q4 24
235.3%
Q3 24
41.5%
Q2 24
0.1%
Q1 24
-93.9%
38.2%
Q4 23
28.0%
EPS (diluted)
RCAT
RCAT
SMLR
SMLR
Q3 25
$-0.16
$1.07
Q2 25
$5.04
Q1 25
$-0.27
$-6.74
Q4 24
$3.63
Q3 24
$0.72
Q2 24
$0.00
Q1 24
$0.78
Q4 23
$0.54

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RCAT
RCAT
SMLR
SMLR
Cash + ST InvestmentsLiquidity on hand
$10.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$253.3M
$459.7M
Total Assets
$286.0M
$596.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RCAT
RCAT
SMLR
SMLR
Q3 25
$10.2M
Q2 25
$13.5M
Q1 25
$9.7M
Q4 24
$8.8M
Q3 24
$6.6M
Q2 24
$7.3M
Q1 24
$62.8M
Q4 23
$57.2M
Stockholders' Equity
RCAT
RCAT
SMLR
SMLR
Q3 25
$253.3M
$459.7M
Q2 25
$383.4M
Q1 25
$28.9M
$161.7M
Q4 24
$27.0M
$230.8M
Q3 24
$85.4M
Q2 24
$78.4M
Q1 24
$49.6M
$77.9M
Q4 23
$71.8M
Total Assets
RCAT
RCAT
SMLR
SMLR
Q3 25
$286.0M
$596.7M
Q2 25
$522.6M
Q1 25
$59.7M
$293.4M
Q4 24
$51.1M
$239.8M
Q3 24
$92.2M
Q2 24
$84.8M
Q1 24
$55.3M
$83.9M
Q4 23
$78.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RCAT
RCAT
SMLR
SMLR
Operating Cash FlowLast quarter
$-23.9M
$-33.0M
Free Cash FlowOCF − Capex
$-24.5M
FCF MarginFCF / Revenue
-254.2%
Capex IntensityCapex / Revenue
6.9%
Cash ConversionOCF / Net Profit
-1.95×
TTM Free Cash FlowTrailing 4 quarters
$-55.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RCAT
RCAT
SMLR
SMLR
Q3 25
$-23.9M
$-33.0M
Q2 25
$514.0K
Q1 25
$-15.9M
$-1.9M
Q4 24
$-10.1M
$7.4M
Q3 24
$6.4M
Q2 24
$4.9M
Q1 24
$-4.1M
$5.6M
Q4 23
$4.4M
Free Cash Flow
RCAT
RCAT
SMLR
SMLR
Q3 25
$-24.5M
Q2 25
Q1 25
$-16.2M
Q4 24
$-10.2M
$7.4M
Q3 24
Q2 24
$4.9M
Q1 24
$-4.2M
$5.6M
Q4 23
$4.4M
FCF Margin
RCAT
RCAT
SMLR
SMLR
Q3 25
-254.2%
Q2 25
Q1 25
-992.9%
Q4 24
59.8%
Q3 24
Q2 24
33.8%
Q1 24
-71.1%
35.3%
Q4 23
29.3%
Capex Intensity
RCAT
RCAT
SMLR
SMLR
Q3 25
6.9%
Q2 25
Q1 25
16.8%
Q4 24
0.0%
Q3 24
0.0%
Q2 24
0.3%
Q1 24
0.8%
0.0%
Q4 23
0.2%
Cash Conversion
RCAT
RCAT
SMLR
SMLR
Q3 25
-1.95×
Q2 25
0.01×
Q1 25
Q4 24
0.25×
Q3 24
1.15×
Q2 24
448.55×
Q1 24
0.93×
Q4 23
1.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RCAT
RCAT

Products$8.5M88%
Services$1.2M12%

SMLR
SMLR

Segment breakdown not available.

Related Comparisons